life expectancy in cervical cancer patients after treatment.
Not Applicable
- Conditions
- Health Condition 1: C538- Malignant neoplasm of overlappingsites of cervix uteri
- Registration Number
- CTRI/2024/02/062998
- Lead Sponsor
- J prasanthi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Histopathologically confirmed cervical cancer patients,squamous cell carcinoma or adenocarcinoma, underwent surgery and chemo radiation with curative intent treatment,and having tumors with FIGO stage I or stage II.
Exclusion Criteria
Cervical cancer patients treated with palliative intent.
Patients previously treated with either surgery or chemo radiation.
Patients treated with radical chemoradiation
Patients who are not on regular follow up.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survivalTimepoint: Overall survival is the period from the date of surgery to date of death
- Secondary Outcome Measures
Name Time Method Disease free survivalTimepoint: Disease free survival is the period from the date of surgery to disease recurrence or last follow up.;ToxicityTimepoint: In this trial we are evaluating late toxicity, which occurs after three months of completion of treatment.